<i>Mycobacterium abscessus</i> pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
dc.contributor.author | Soza, Alejandro | |
dc.contributor.author | Labbe, Pilar | |
dc.contributor.author | Arrese, Marco | |
dc.contributor.author | Riquelme, Arnoldo | |
dc.contributor.author | Barrera, Francisco | |
dc.contributor.author | Benitez, Carlos | |
dc.contributor.author | Huete, Alvaro | |
dc.contributor.author | Elvira Balcells, M. | |
dc.contributor.author | Labarca, Jaime | |
dc.date.accessioned | 2025-01-23T21:37:41Z | |
dc.date.available | 2025-01-23T21:37:41Z | |
dc.date.issued | 2015 | |
dc.description.abstract | The first generation protease inhibitors has been the mainstay of hepatitis C treatment for the last couple of years, showing marked improvement in sustained virological response, but also increased side effects. Infection has emerged as a common complication of telaprevir and boceprevir in combination with peginterferon and ribavirin, usually caused by common pathogens. We present the case of a 65 years old man who developed a Mycobacterium abscessus pulmonary infection during treatment with telaprevir, peginterferon and ribavirin. The patient was successfully treated with amikacin, imipenem and chlarithro-mycin. The present case is relevant for increasing awareness for recognition of opportunistic-infections and particularly nontuberculous mycobacterial infections in patients receiving triple therapy for chronic hepatitis C, especially in cirrhotic subjects who develop significant lymphopenia. | |
dc.description.funder | FONDECYT from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) | |
dc.fuente.origen | WOS | |
dc.identifier.issn | 1665-2681 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/101580 | |
dc.identifier.wosid | WOS:000350903700016 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 136 | |
dc.pagina.inicio | 132 | |
dc.revista | Annals of hepatology | |
dc.rights | acceso restringido | |
dc.subject | HCV | |
dc.subject | Boceprevir | |
dc.subject | Peginterferon | |
dc.subject | Ribavirin | |
dc.subject | Lymphopenia | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | <i>Mycobacterium abscessus</i> pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin | |
dc.type | artículo | |
dc.volumen | 14 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |